NEW YORK (GenomeWeb News) – Ayoxxa Biosystems announced today that it has netted €2.6 million ($3.4 million) in a Series A financing round.

The Cologne, Germany-based firm said it will use the proceeds to further develop and scale-up production of in situ encoded bead-based arrays that allow the simultaneous measurement of multiple proteins from small amounts of sample material.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.